Department of BIN Convergence Technology, Department of Polymer Nano Science & Technology and Polymer Materials Fusion Research Center , Chonbuk National University , 567 Baekje-daero , Deokjin-gu, Jeonju-si , Jeollabuk-do 54896 , Republic of Korea.
Department of Bioengineering , University of Washington , 3720 15th Avene Northeast , Box 355061, Seattle , Washington 98195 , United States.
ACS Appl Mater Interfaces. 2018 Oct 3;10(39):32955-32964. doi: 10.1021/acsami.8b08119. Epub 2018 Sep 18.
There is a significant rise in the bone grafts demand worldwide to treat bone defects owing to continuous increase in conditions such as injury, trauma, diseases, or infections. Therefore, development of three-dimensional scaffolds has evolved as a reliable technology to address the current limitations for bone tissue regeneration. Mimicking the natural bone, in this study, we have designed a silk fibroin/hydroxyapatite scaffold inlaid with a bioactive phytochemical (quercetin) at different concentrations for promoting osteogenesis, especially focusing on quercetin ability for enhancing bone health. Characterization of the quercetin/silk fibroin/hydroxyapatite (Qtn/SF/HAp) scaffolds showed an increased pore size and irregular porous microstructure with good mechanical strength. The Qtn (low-content)/SF/HAp scaffold was found to be an efficient cell carrier facilitating cellular growth, osteogenic differentiation, and proliferation as compared to SF/HAp and Qtn (high-content)/SF/HAp scaffolds. However, Qtn (high-content)/SF/HAp was observed to inhibit cell proliferation without any effects on cell viability. In vitro and in vivo outcomes studied using bone marrow-derived mesenchymal stem cells (rBMSCs) confirm the cytocompatibility, osteogenic differentiation ability, and prominent upregulation of the bone-specific gene expressions for the rBMSCs-seeded Qtn/SF/HAp scaffolds. In particular, the implanted Qtn (low-content)/SF/HAp scaffolds at the bone defect site were found to be well-attached and amalgamated with the surrounding tissues with approximately 80% bone volume recovery at 6 weeks after surgery as compared with other groups. Based on the aforementioned observations highlighting the quercetin efficiency for bone regeneration, the as-synthesized Qtn (low-content)/SF/HAp scaffolds can be envisioned to provide a biomimetic bone-like microenvironment promoting rBMSCs differentiation into osteoblast, thus suggesting a potential alternative graft for high-performance regeneration of bone tissues.
由于创伤、疾病或感染等情况的持续增加,全球对骨移植物的需求显著增加,以治疗骨缺损。因此,三维支架的开发已经发展成为一种可靠的技术,可以解决当前骨组织再生的局限性。在本研究中,为了模仿天然骨,我们设计了一种丝素蛋白/羟基磷灰石支架,其中嵌入了不同浓度的生物活性植物化学物质(槲皮素),以促进成骨,特别是关注槲皮素增强骨骼健康的能力。槲皮素/丝素蛋白/羟基磷灰石(Qtn/SF/HAp)支架的特性表明,孔径增大,多孔结构不规则,机械强度良好。与 SF/HAp 和 Qtn(高含量)/SF/HAp 支架相比,Qtn(低含量)/SF/HAp 支架被发现是一种有效的细胞载体,有利于细胞生长、成骨分化和增殖。然而,观察到 Qtn(高含量)/SF/HAp 抑制细胞增殖,而对细胞活力没有影响。使用骨髓间充质干细胞(rBMSCs)进行的体外和体内研究结果证实了 Qtn/SF/HAp 支架的细胞相容性、成骨分化能力以及对 rBMSCs 种子的骨特异性基因表达的显著上调。特别是,与其他组相比,在手术后 6 周时,在骨缺损部位植入的 Qtn(低含量)/SF/HAp 支架与周围组织附着良好并融合,骨体积恢复约 80%。基于上述观察结果强调了槲皮素在骨再生方面的效率,所合成的 Qtn(低含量)/SF/HAp 支架可以为促进 rBMSCs 分化为成骨细胞的仿生骨样微环境提供想象空间,从而为高性能骨组织再生提供潜在的替代移植物。